IL4I1 and cancer: It is reported that cancers expressed high levels of IL4I1, inducing the differentiation of Tregs, promoting CD8+ T cell death, recruiting immunosuppressive TAMs and suppressing T cell proliferation and function via the Kyn-AHR axis [42].